findmyKOL
Clinical trialNCT02275351CompletedPhase 2Interventional

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

SponsorBiosplice Therapeutics, Inc.Enrollment310Androgenetic Alopecia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Encinitas, California, United States

  • Facility name not stated

    San Diego, California, United States

  • Facility name not stated

    New Haven, Connecticut, United States

  • Facility name not stated

    Miami, Florida, United States

  • Facility name not stated

    West Palm Beach, Florida, United States

  • Facility name not stated

    Plainfield, Indiana, United States

  • Facility name not stated

    Wichita, Kansas, United States

  • Facility name not stated

    Clinton Township, Michigan, United States

  • Facility name not stated

    Detroit, Michigan, United States

  • Facility name not stated

    Fridley, Minnesota, United States

  • Facility name not stated

    Albuquerque, New Mexico, United States

  • Facility name not stated

    New York, New York, United States

  • Facility name not stated

    Stony Brook, New York, United States

  • Facility name not stated

    Winston-Salem, North Carolina, United States

  • Facility name not stated

    Cleveland, Ohio, United States

  • Facility name not stated

    Portland, Oregon, United States

  • Facility name not stated

    Portland, Oregon, United States

  • Facility name not stated

    Austin, Texas, United States

  • Facility name not stated

    College Station, Texas, United States

  • Facility name not stated

    Dallas, Texas, United States

  • Facility name not stated

    Houston, Texas, United States

  • Facility name not stated

    Salt Lake City, Utah, United States

  • Facility name not stated

    Lynchburg, Virginia, United States

  • Facility name not stated

    Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2014
Primary completion
30 Nov 2015
Completion
30 Nov 2015
Last update posted
17 Feb 2020
Registered enrollment
310
Registry id
NCT02275351

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.